Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Levered Free Cash Flow (FCF)

Amag Pharmaceuticals Levered Free Cash Flow (FCF) Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Levered Free Cash Flow (FCF) from 2010 to 2020.
  • Amag Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending June 06, 2020 was $26m a 564.33% increase of 147m year over year
  • Amag Pharmaceuticals Levered Free Cash Flow (FCF) for the last 12 months ending June 06, 2020 was $-133m a 35.20% decrease of -47m year over year
  • Amag Pharmaceuticals Annual Levered Free Cash Flow (FCF) for 2019 was $-52m a 188.18% decrease of -98m from 2018
  • Amag Pharmaceuticals Annual Levered Free Cash Flow (FCF) for 2018 was $46m a 40.78% increase of 19m from 2017
  • Amag Pharmaceuticals Annual Levered Free Cash Flow (FCF) for 2017 was $27m a -731.26% decrease of -199m from 2016
Other Cash Flow Metrics:
  • Amag Pharmaceuticals Cash Flow from Operations for the quarter ending December 12, 2018 was $-34m a 162.36% decrease of -55m year over year
  • Amag Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $122m a -29.53% decrease of -36m year over year
View Chart On Koyfin

Quarterly AMAG Levered Free Cash Flow (FCF) Data

06/2020$26m
03/2020$-38m
12/2019$4m
09/2019$-121m
06/2019$71m
03/2019$-2m
12/2018$-31m
09/2018$39m
03/2018$105m
12/2017$-65m

Annual AMAG Levered Free Cash Flow (FCF) Data

2019$-52m
2018$46m
2017$27m
2016$227m
2015$230m
2014$19m
2013$2m
2012$-5m
2011$-28m
2010$-23m